Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | PHPT1 | Q9NRX4 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.46 |
| ▸ | ABAT | P80404 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14733275 | 0.93 | MAPT (0.59) | MAPTKDM4EL3MBTL1USP2LMNA | |
| SCHEMBL11877292 | 0.82 | ALDH1A1 (0.51) | MAPTLMNASMN1; SMN2ALDH1A1CA1 | |
| SCHEMBL28937850 | 0.81 | VCAM1 (0.49) | MAPK1TSHR | |
| Nitrogen SCHEMBL11494351 | 0.79 | ALDH1A1 (0.47) | MAPTLMNAMAPK1TSHRSMN1; SMN2 | |
| SCHEMBL4215530 | 0.78 | DTYMK (0.53) | MAPTLMNATSHRALDH1A1ALOX15 | |
| SCHEMBL1858467 | 0.76 | ALDH1A1 (0.56) | MAPTLMNAMAPK1TSHRSMN1; SMN2 | |
| SCHEMBL12405284 | 0.76 | MAPT (0.59) | MAPTKDM4EL3MBTL1USP2LMNA | |
| SCHEMBL2617457 | 0.75 | DTYMK (0.45) | MAPTLMNATSHRALDH1A1ALOX15 | |
| SCHEMBL6651702 | 0.73 | TSHR (0.55) | MAPTLMNAMAPK1TSHRSMN1; SMN2 | |
| SCHEMBL11881555 | 0.72 | ALDH1A1 (0.51) | MAPTLMNASMN1; SMN2ALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130053598-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | ZYLUM BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE II KG (DE) | 2013-02-28 | — | — | US | disclosed |
| EP-2421822-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | Zylum Beteiligungsgesellschaft mbH & Co. Patente II KG (DE) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010122105-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | ZYLUM BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE II KG (DE) | 2010-10-28 | — | — | WO | disclosed |
| EP-2243768-A1 | Phenolic diazonium salt, method for its production and its application | Zylum Beteiligungsgesellschaft mbH & Co. Patente II KG (DE) | 2010-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053598-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | CBR3, CBR1, NOX3 | MAPT 4849/4885KDM4E 2658/4885L3MBTL1 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.